Delayed Sleep Phase
10
4
4
3
Key Insights
Highlights
Success Rate
60% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 85/100
20.0%
2 terminated out of 10 trials
60.0%
-26.5% vs benchmark
0%
0 trials in Phase 3/4
33%
1 of 3 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (10)
Effect of Bright Light Therapy on Idiopathic Scoliosis
Delayed Sleep Timing in Teens Study
Biomarkers for Circadian Timing in Healthy Adults
Breath Biomarkers for Sleep Loss and Circadian Timing
Better Sleep Study
Pathophysiology of Circadian Rhythm Delayed Sleep Wake Phase Disorder
Effects of Cognitive Behavioural Therapy and Bright Light Therapy for Insomnia in Adolescents With Evening Chronotype
The Reducing Risk Study
Improving Access to Care: Testing an Integrated Care Mobile Health Intervention
Circadian Phase Assessments at Home